INmune Bio Statistics Share Statistics INmune Bio has 26.59M
shares outstanding. The number of shares has increased by 4.68%
in one year.
Shares Outstanding 26.59M Shares Change (YoY) 4.68% Shares Change (QoQ) -12.71% Owned by Institutions (%) 26.27% Shares Floating 18.9M Failed to Deliver (FTD) Shares 79,492 FTD / Avg. Volume 2.25%
Short Selling Information The latest short interest is 5.33M, so 20.05% of the outstanding
shares have been sold short.
Short Interest 5.33M Short % of Shares Out 20.05% Short % of Float 24.16% Short Ratio (days to cover) 1.81
Valuation Ratios The PE ratio is -2.21 and the forward
PE ratio is -1.39.
INmune Bio's PEG ratio is
-0.08.
PE Ratio -2.21 Forward PE -1.39 PS Ratio 6652.75 Forward PS 510.4 PB Ratio 2.9 P/FCF Ratio -2.79 PEG Ratio -0.08
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for INmune Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.14,
with a Debt / Equity ratio of 0.01.
Current Ratio 3.14 Quick Ratio 3.14 Debt / Equity 0.01 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $1.08K Profits Per Employee $-3.24M Employee Count 13 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -68% in the
last 52 weeks. The beta is 0.98, so INmune Bio's
price volatility has been higher than the market average.
Beta 0.98 52-Week Price Change -68% 50-Day Moving Average 2.65 200-Day Moving Average 5.99 Relative Strength Index (RSI) 31.47 Average Volume (20 Days) 3,526,940
Income Statement In the last 12 months, INmune Bio had revenue of 14K
and earned -42.08M
in profits. Earnings per share was -2.11.
Revenue 14K Gross Profit 14K Operating Income -42.63M Net Income -42.08M EBITDA -42.08M EBIT -42.63M Earnings Per Share (EPS) -2.11
Full Income Statement Balance Sheet The company has 20.92M in cash and 384K in
debt, giving a net cash position of 20.54M.
Cash & Cash Equivalents 20.92M Total Debt 384K Net Cash 20.54M Retained Earnings -163.1M Total Assets 37.68M Working Capital 27.45M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -33.36M
and capital expenditures 0, giving a free cash flow of -33.36M.
Operating Cash Flow -33.36M Capital Expenditures n/a Free Cash Flow -33.36M FCF Per Share -1.67
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -304535.71% and -300585.71%.
Gross Margin 100% Operating Margin -304535.71% Pretax Margin -300585.71% Profit Margin -300585.71% EBITDA Margin -300585.71% EBIT Margin -304535.71% FCF Margin -238292.86%
